← Back to Search

Behavioral Intervention

Group Cognitive Behavioral Therapy for Cancer Distress

N/A

Recruiting

Led By Shawna L. Ehlers, Ph.D., L.P.

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age >= 18-years

Cancer diagnosis with predicted survival > 1 year

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at baseline, 1, 3, 6, and 12 months

Awards & highlights

Study Summary

This trial tests if group CBMS sessions reduce stress & psychological distress for cancer patients. It teaches how to cope with cancer-related stressors.

Who is the study for?

This trial is for adults over 18 with any type of cancer who have been treated within the last year or are planning treatment, and expect to live more than a year. They must be feeling moderately distressed, as shown by a specific stress test score or doctor's opinion, but able to participate in group therapy.Check my eligibility

What is being tested?

The study examines if group sessions using cognitive behavioral therapy specifically designed for cancer-related stress can help reduce emotional distress in cancer patients. It focuses on teaching skills to manage the psychological impact of living with cancer.See study design

What are the potential side effects?

Cognitive behavioral therapy is generally safe but may sometimes cause temporary increases in distress due to discussing difficult topics. Emotional discomfort is possible when learning new coping strategies.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

My doctor expects me to live more than a year with my cancer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at baseline, 1, 3, 6, and 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at baseline, 1, 3, 6, and 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, 1, 3, 6, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in post-traumatic stress (PTS) score

Secondary outcome measures

Anxiety

Change in post-traumatic growth (PTG) score

Change in self-efficacy score

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Group I (CBCSM)Experimental Treatment2 Interventions

Patients participate in five CBCSM group sessions on study. Patients complete questionnaires throughout the trial.

Group II: Group II (no CBCSM)Active Control1 Intervention

Patients complete questionnaires throughout the trial.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Cognitive Behavior Therapy

2010

Completed Phase 3

~2630

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,216 Previous Clinical Trials

3,767,088 Total Patients Enrolled

Shawna L. Ehlers, Ph.D., L.P.Principal InvestigatorMayo Clinic in Rochester

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitments for this research being accepted at the present?

"According to information available on clinicaltrials.gov, this investigation into the efficacy of a particular treatment is actively enrolling patients. The project was first publicized in December 2017 and has been updated as recently as August 2023."

Answered by AI

How many participants has this research attracted thus far?

"Indeed, the details on clinicaltrials.gov assert that this investigation is currently enrolling volunteers. The trial was initially posted to the website in December of 2017 and recently modified in August of 2023. 400 participants must be recruited from a single location for it to move forward."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients

Shawna L. Ehlers, Ph.D., L.P. 2017. "Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06015932.